Close Menu

NEW YORK – Invitae today announced a $50 million deal to acquire Jungla, an artificial intelligence-driven biotech firm that it believes will enhance its variant interpretation capabilities.

Jungla has developed the cloud-based Functional Modeling Platform, which uses machine learning to integrate functional, structural, and computational data and create predictive models that can be used to interpret the clinical significance of genomic variants. Invitae sees this technology as complementary to its own variant classification and interpretation method, called Sherloc.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.